Literature DB >> 31345131

Corticosterone-Mediated Body Weight Loss Is an Important Catabolic Process for Poststroke Immunity and Survival.

Jiwon Yang1, Eunhee Kim1, Cesar Beltran1, Sunghee Cho1,2.   

Abstract

Background and Purpose- Stroke-induced acute severe body weight (BW) loss is associated with a high rate of mortality during a critical poststroke period. Several interventions to reduce weight loss, however, have not been successful. Currently, the biological significance of this extraordinary catabolic process is not well understood. Spleen-derived monocytes/macrophages (MMs) are the major immune cells recruited to the injured brain. The trafficking of MMs has been shown to be important for tissue repair and recovery. The purpose of the study is to investigate whether the BW reduction is essential for MM-mediated immune response for mice to survive and whether a corticosterone-mediated catabolic event underlies the processes. Methods- C57BL/6 male mice (12-week-old) were subjected to transient middle cerebral artery occlusion. BW, total MMs, and their Ly-6Chigh and Ly-6Clow subsets were determined in the spleen, blood, and the brain in poststroke mice. Poststroke survival rate and MM subsets were determined in mice with adrenalectomy, sham-adrenalectomy, and adrenalectomy mice supplemented with corticosterone. Results- Stroke reduced BW with a maximum reduction at day 3 poststroke (17.2±5.2%). The reduction at day 3 was positively linked to injury severity and selective depletion of MMs, but no other types of immune cells, in the spleen. Notably, the splenic MM depletion was significantly greater in mice with severe BW reduction (≥18% at day 3). In the blood, stroke depleted circulating MMs to a similar degree in animals with moderate and severe BW loss. Ly-6C+ monocyte infiltration in the poststroke brain was greater in mice with severe BW loss. Blocking the catabolic process by adrenalectomy significantly increased poststroke mortality, but the mortality was partially rescued by corticosterone supplement in adrenalectomy mice. Conclusions- Stroke-induced BW loss facilitates MM-mediated immune response, and the adrenal corticosterone-mediated catabolic process is necessary for poststroke survival. Visual Overview- An online visual overview is available for this article.

Entities:  

Keywords:  corticosterone; immunity; macrophages; monocyte; mortality

Year:  2019        PMID: 31345131      PMCID: PMC6710102          DOI: 10.1161/STROKEAHA.119.026053

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  45 in total

1.  Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate.

Authors:  A H Terpstra
Journal:  J Nutr       Date:  2001-07       Impact factor: 4.798

2.  Macrophage heterogeneity and tissue lipids.

Authors:  Siamon Gordon
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Molecular mechanisms of life- and health-span extension: role of calorie restriction and exercise intervention.

Authors:  Christy S Carter; Tim Hofer; Arnold Y Seo; Christian Leeuwenburgh
Journal:  Appl Physiol Nutr Metab       Date:  2007-10       Impact factor: 2.665

4.  Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats.

Authors:  C V Borlongan; C E Stahl; E Redei; Y Wang
Journal:  Neuroreport       Date:  1999-11-26       Impact factor: 1.837

5.  Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

Authors:  Halina Offner; Sandhya Subramanian; Susan M Parker; Chunhe Wang; Michael E Afentoulis; Anne Lewis; Arthur A Vandenbark; Patricia D Hurn
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

6.  Quadriceps muscle weakness following acute hemiplegic stroke.

Authors:  M L Harris; M I Polkey; P M Bath; J Moxham
Journal:  Clin Rehabil       Date:  2001-06       Impact factor: 3.477

7.  Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.

Authors:  Christian Meisel; Konstantin Prass; Johann Braun; Ilya Victorov; Tilo Wolf; Dirk Megow; Elke Halle; Hans-Dieter Volk; Ulrich Dirnagl; Andreas Meisel
Journal:  Stroke       Date:  2003-12-18       Impact factor: 7.914

8.  Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke.

Authors:  T Olsson; N Marklund; Y Gustafson; B Näsman
Journal:  Stroke       Date:  1992-11       Impact factor: 7.914

9.  Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis.

Authors:  Heinrich J Audebert; Michaela M Rott; Thomas Eck; Roman L Haberl
Journal:  Stroke       Date:  2004-07-22       Impact factor: 7.914

10.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.

Authors:  Matthias Nahrendorf; Filip K Swirski; Elena Aikawa; Lars Stangenberg; Thomas Wurdinger; Jose-Luiz Figueiredo; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  3 in total

1.  Remote Postischemic Conditioning Promotes Stroke Recovery by Shifting Circulating Monocytes to CCR2+ Proinflammatory Subset.

Authors:  Jiwon Yang; Mustafa Balkaya; Cesar Beltran; Ji Hoe Heo; Sunghee Cho
Journal:  J Neurosci       Date:  2019-08-19       Impact factor: 6.167

2.  Intermittent hypoxia promotes the recovery of motor function in rats with cerebral ischemia by regulating mitochondrial function.

Authors:  Yue Su; Changkai Ke; Chen Li; Chuan Huang; Chunxiao Wan
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

3.  Exercise Intervention Modulates Synaptic Plasticity by Inhibiting Excessive Microglial Activation via Exosomes.

Authors:  Chen Li; Jiayi Hu; Wenhong Liu; Changkai Ke; Chuan Huang; Yifan Bai; Bingchen Pan; Junyi Wang; Chunxiao Wan
Journal:  Front Cell Neurosci       Date:  2022-07-19       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.